But it can also reduce your risk of these conditions if youre high-risk, including people with diabetes. GLP-1s and Metformin Are Most Beneficial When Combined Diabetes is a complex health condition, explains King
Cardiovascular Health: Semaglutide extends beyond blood sugar control, offering potential cardiovascular benefits and reducing associated risks
While the study focused on patients with type 2 diabetes-related mild cognitive impairment, and the intervention did show improvement in cognitive measures, the olfactory training also importantly further showed elevated overall olfactory performance
This American Heart Month, Take a Step Toward Prevention Heart disease remains the leading cause of death in the United States but many risk factors are within your control
The largest body of evidence supports GLP-1 monotherapy as the first-line pharmacological approach for weight loss in eligible patients, with semaglutide and tirzepatide demonstrating sustained weight reductions of 15 to 22 percent of baseline body weight
These treatments have helped people lose weight when diet and exercise havent been enough